Literature DB >> 26293940

MEDICINE. Global control of hepatitis C virus.

Andrea L Cox1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26293940     DOI: 10.1126/science.aad1302

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  53 in total

Review 1.  Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era.

Authors:  O Falade-Nwulia; M S Sulkowski; A Merkow; C Latkin; S H Mehta
Journal:  J Viral Hepat       Date:  2018-03       Impact factor: 3.728

Review 2.  [Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E].

Authors:  R Bartenschlager; M Cornberg; T Pietschmann
Journal:  Internist (Berl)       Date:  2017-07       Impact factor: 0.743

3.  Exosomal MicroRNAs Derived From Umbilical Mesenchymal Stem Cells Inhibit Hepatitis C Virus Infection.

Authors:  Xijing Qian; Chen Xu; Shuo Fang; Ping Zhao; Yue Wang; Houqi Liu; Wen Yuan; Zhongtian Qi
Journal:  Stem Cells Transl Med       Date:  2016-08-05       Impact factor: 6.940

4.  Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c mice.

Authors:  Santa Olivera; Angel Perez; Viviana Falcon; Dioslaida Urquiza; Dagmara Pichardo; Gillian Martinez-Donato
Journal:  Arch Virol       Date:  2020-02-03       Impact factor: 2.574

5.  Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.

Authors:  Brian G Pierce; Zhen-Yong Keck; Patrick Lau; Catherine Fauvelle; Ragul Gowthaman; Thomas F Baumert; Thomas R Fuerst; Roy A Mariuzza; Steven K H Foung
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-26       Impact factor: 11.205

6.  Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.

Authors:  Michael Logan; John Law; Jason Alexander Ji-Xhin Wong; Darren Hockman; Amir Landi; Chao Chen; Kevin Crawford; Juthika Kundu; Lesley Baldwin; Janelle Johnson; Anita Dahiya; Gerald LaChance; Joseph Marcotrigiano; Mansun Law; Steven Foung; Lorne Tyrrell; Michael Houghton
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

7.  Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.

Authors:  Leopold Kong; David E Lee; Rameshwar U Kadam; Tong Liu; Erick Giang; Travis Nieusma; Fernando Garces; Netanel Tzarum; Virgil L Woods; Andrew B Ward; Sheng Li; Ian A Wilson; Mansun Law
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

8.  Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.

Authors:  Madeleine C Mankowski; Valerie J Kinchen; Lisa N Wasilewski; Andrew I Flyak; Stuart C Ray; James E Crowe; Justin R Bailey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-18       Impact factor: 11.205

9.  The HCV care continuum does not end with cure: A call to arms for the prevention of reinfection.

Authors:  Oluwaseun Falade-Nwulia; Mark Sulkowski
Journal:  J Hepatol       Date:  2016-11-02       Impact factor: 25.083

Review 10.  Viral evasion and challenges of hepatitis C virus vaccine development.

Authors:  Brian G Pierce; Zhen-Yong Keck; Steven Kh Foung
Journal:  Curr Opin Virol       Date:  2016-09-19       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.